SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000926617-16-000104
Filing Date
2016-11-10
Accepted
2016-11-10 16:16:45
Documents
39
Period of Report
2016-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q c617-20160930x10q.htm 10-Q 969934
2 EX-31.1 c617-20160930xex31_1.htm EX-31.1 15163
3 EX-31.2 c617-20160930xex31_2.htm EX-31.2 15352
4 EX-32.1 c617-20160930xex32_1.htm EX-32.1 11947
5 GRAPHIC c617-20160930x10qg001.jpg GRAPHIC 18865
  Complete submission text file 0000926617-16-000104.txt   3040213

Data Files

Seq Description Document Type Size
6 EX-101.INS c617-20160930.xml EX-101.INS 480433
7 EX-101.SCH c617-20160930.xsd EX-101.SCH 26125
8 EX-101.CAL c617-20160930_cal.xml EX-101.CAL 31403
9 EX-101.DEF c617-20160930_def.xml EX-101.DEF 82101
10 EX-101.LAB c617-20160930_lab.xml EX-101.LAB 207473
11 EX-101.PRE c617-20160930_pre.xml EX-101.PRE 168961
Mailing Address 12117 BEE CAVES ROAD BUILDING THREE SUITE 100 AUSTIN TX 78738
Business Address 12117 BEE CAVES ROAD BUILDING THREE SUITE 100 AUSTIN TX 78738 512-519-0400
VERMILLION, INC. (Filer) CIK: 0000926617 (see all company filings)

IRS No.: 330595156 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-34810 | Film No.: 161988250
SIC: 2835 In Vitro & In Vivo Diagnostic Substances